Aspen aerogels inc (ASPN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Total revenue

139,375

104,361

111,631

117,738

-

-

-

-

Product

-

-

-

-

120,532

99,259

82,057

60,389

Research services

-

-

-

-

1,986

3,140

4,037

3,064

Total revenue

-

-

-

-

122,518

102,399

86,094

63,453

Cost of revenue:
Product

-

-

-

-

96,865

83,677

73,399

70,025

Research services

-

-

-

-

1,005

1,642

1,964

1,396

Gross profit

26,284

12,669

18,671

23,311

24,648

17,080

10,731

-7,968

Operating expenses:
Research and development

8,407

6,319

6,180

5,306

5,253

5,980

5,159

5,142

Sales and marketing

15,557

13,794

12,604

11,810

10,562

10,290

9,271

8,564

General and administrative

16,479

19,116

19,023

17,415

15,068

16,853

12,833

11,299

Impairment of construction in progress

-

7,356

-

-

-

-

-

-

Write-off of construction in progress

-

-

-

-

-

-

3,440

-

Total operating expenses

40,443

46,585

37,807

34,531

30,883

33,123

30,703

25,005

Loss from operations

-14,159

-33,916

-19,136

-11,220

-6,235

-16,043

-19,972

-32,973

Financing costs

-

-

-

-

-

47

-

-

Interest expense, net

-406

-524

-185

-147

-182

-50,281

-30,599

-

Postponed financing costs

-

-

-

656

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-21,790

Gain on extinguishment of convertible notes

-

-

-

-

-

-

8,898

-

Loss on exchange of convertible notes

-

-

-

-

-

-

-5,697

-

Debt extinguishment costs

-

-

-

-

-

-

-

-1,379

Costs associated with postponed public offering

-

-

-

-

-

-

241

-

Total interest expense, net

-406

-524

-185

-803

-182

-50,281

-27,639

-23,169

Net loss

-14,565

-34,440

-19,321

-12,023

-6,417

-66,324

-47,611

-56,142

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

1,338

-8,941

Net loss per share:
Basic and diluted

-0.60

-1.45

-0.83

-0.52

-0.28

-5.37

-

-

Basic

-

-

-

-

-

-

426.52

-2,851.08

Diluted

-

-

-

-

-

-

410.56

-2,851.08

Weighted-average common shares outstanding:
Basic and diluted

24,099

23,738

23,390

23,139

22,986

12,349

-

-

Basic

-

-

-

-

-

-

3

3

Diluted

-

-

-

-

-

-

3

3

Product [Member]
Total revenue

136,934

102,123

109,590

115,490

-

-

-

-

Cost of revenue

111,759

90,660

92,052

93,123

-

-

-

-

Research Services [Member]
Total revenue

2,441

2,238

2,041

2,248

-

-

-

-

Cost of revenue

1,332

1,032

908

1,304

-

-

-

-